Mr. Charles MaLette reports

SURENANO ANNOUNCES CLOSING OF $1,250,000 PRIVATE PLACEMENT

Surenano Science Ltd., as a follow-up to its news release dated Nov. 5, 2025, has closed its non-brokered private placement to raise $1.25-million through the issuance of 10 million units at a price of 12.5 cents per unit.

Each unit comprises one common share and one common share purchase warrant, with each warrant entitling the holder thereof to acquire one common share in the capital of the company at a price of 35 cents per common share for a period of 24 months from the date of issuance. The warrants will be subject to an acceleration provision, such that if at any time after the date that is four months and one day after the closing, the company's shares trade on the Canadian Securities Exchange at a closing price of 50 cents or greater per share for a period of 10 consecutive trading days, the company may accelerate the expiry of the warrants by giving notice to the holders thereof and, in such case, the warrant will expire on the 30th day after the date of such notice.

In consideration for their services in introducing subscribers to the company under the private placement, finders may receive commission of 6 per cent in cash and 6 per cent in common share purchase warrants, exercisable to purchase one common share at a price of 35 cents for a period of 24 months.

In connection with the private placement, the company paid cash commissions of $75,000 and issued an aggregate of 600,000 finders' warrants to certain brokerage firms and agents for introducing subscribers to the company. Each finder's warrant entitles the holder to receive one common share in the capital of the company at a price of 35 cents per cosmon Share for a period of 24 months from the date of issuance, subject to the acceleration provision.

The common shares, warrants and finders' warrants, together with all securities that may be issued on exercise, are subject to a hold period under applicable Canadian securities laws expiring four months and one day from the date of issuance.

The company intends to use proceeds of the private placement for operating expenses, including legal and audit fees, general working capital, expenses related to exploring new markets for its Surenano surfactant, and continuing to evaluate potential business combinations with complementary companies. In the event that the board approves one or more potential transactions, then the proceeds will also be used toward entering into one or more agreements relating to business combinations or acquisitions, and completing the business combination or acquisition transactions. The forward-looking information contained in this news release represents the expectations of the company as of the date of this news release and, accordingly, is subject to change after such date. The company expressly disclaims any intention or obligation to update or revise any forward-looking information, whether as a result of new information, future events or otherwise, except as expressly required by applicable securities law.

About Surenano Science Ltd.

The business of Surenano Science is the sale and distribution of the Surenano surfactant, which is a ready-to-mix food-grade compound that provides the base for high performance nanoemulsions to create incredibly homogeneous and stable products while maximizing bioavailability, clarity and taste. The company has an exclusive licence to distribute the Surenano surfactant within Canada, and Oklahoma and Colorado.

We seek Safe Harbor.